Turkey (2025, preliminary)
2,395.0
USD PPP per capita
-84.3 YoY
Government share
74.5
% of total (2024)
Private share
25.5
% of total (2024)
10-year change
+130.2
% since 2015

Data

Current Health Expenditure per Capita in Turkey (2025) — source data. OECD.
Year USD PPP per capita YoY Change
2025 2,395 -3.4%
2024 2,479.3 +17.9%
2023 2,102.5 +27.1%
2022 1,653.8 +4.1%
2021 1,588.3 +14.9%
2020 1,382.4 +5.5%
2019 1,310.8 +8.8%
2018 1,205.3 +2.5%
2017 1,175.7 +4.2%
2016 1,128.8 +8.5%
2015 1,040.4 +3.3%
2014 1,006.8 +6.2%
2013 947.7 +5.9%
2012 894.7 +0.7%
2011 888.3 +5.3%
2010 843.7 +3.5%
2009 815.1 +1.0%
2008 807.1 +10.0%
2007 733.4 +8.2%
2006 677.9 +15.3%
2005 588.1 +5.3%
2004 558.6 +9.6%
2003 509.7 -2.0%
2002 520 +9.9%
2001 473 +9.5%
2000 432.1 +17.1%
1999 369.1 n/a

About this Dataset

Turkey recorded 2,395.0 USD PPP per capita in current health expenditure in 2025, an OECD preliminary estimate down -84.3 from 2024's finalized figure of 2,479.3. Spending has grown in most years since 1999, when the series started at 369.1 USD PPP, with the steepest jump, +448.7, coming in 2023 — likely reflecting the effect of high domestic inflation on nominal figures ahead of PPP conversion.

Government and compulsory insurance schemes typically fund around three-quarters of this spending: in 2024 they covered about 74.5% of the total (1,848.0 USD PPP per capita), with voluntary insurance and household out-of-pocket payments making up the remaining 25.5% (631.3 USD PPP). That split has stayed fairly consistent across the observed years.

Compared with the OECD average, which is typically cited around 4,500 USD PPP per capita, Turkey's 2,479.3 USD PPP in 2024 is likely close to half that level. It runs modestly above Mexico (1,653.4 USD PPP in 2024), a fellow OECD member with a broadly comparable income profile. The chart above shows the full 1999–2025 trend; the table below lists annual values with year-on-year changes.

Data sourced from the OECD System of Health Accounts (SHA) via SDMX REST API, filtered to Turkey (TUR), total current health expenditure across all financing schemes, converted to USD at purchasing power parity. The most recent year is flagged provisional by the OECD and may be revised.

Frequently Asked Questions

This indicator tracks total current spending on health care per person in Turkey, converted to USD at purchasing power parity (PPP) so levels are comparable across countries. It covers spending by government schemes, private insurance, and household out-of-pocket payments, published annually by the OECD under its System of Health Accounts (SHA). The most recent reading is 2,395.0 USD PPP in 2025 (preliminary).

The series runs through 2025, though that year is flagged as a preliminary OECD estimate. The last fully finalized observation is 2024, at 2,479.3 USD PPP per capita — meaning the 2025 figure of 2,395.0 is likely to be revised as Turkey's national health accounts are finalized in a future OECD update.

The OECD average is typically cited around 4,500 USD PPP per capita, so Turkey's 2,479.3 USD PPP in 2024 sits well below that benchmark — roughly half. Turkey's spending is also modestly above Mexico, which recorded 1,653.4 USD PPP per capita in 2024, though direct comparisons depend on using data from the same vintage for each country.

In 2024, government and compulsory schemes covered an estimated 1,848.0 USD PPP per capita (about 74.5% of the total), while voluntary insurance and household out-of-pocket payments accounted for roughly 631.3 USD PPP (about 25.5%). Government financing has typically covered around three-quarters of current health spending across the observed years.

Per-capita spending has risen in most years since 1999, from 369.1 USD PPP that year to 2,395.0 USD PPP in 2025 — an increase of roughly 130.2% just since 2015. The largest single-year jump came in 2023, at +448.7 USD PPP, likely reflecting the effect of high domestic inflation on nominal health spending figures before PPP conversion.